Eli Lilly and Company (NYSE:LLY) Price Target Raised to $1,600.00
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price lifted by equities research analysts at Cantor Fitzgerald from $1,440.00 to $1,600.00 in a research report issued on Monday, Benzinga reports. The firm presently has an “overweight” rating on the stock. Cantor Fitzgerald‘s price objective indicates a potential upside of 13.02% from […]
2 Nov 09:15 · The Cerbat Gem